In May 2022, we checked the impact of the PROSPER trial on our recommendations on strategies for reducing arm and shoulder mobility problems after breast cancer surgery and will update the guideline. For more information, see the May 2022 surveillance decision.

For further information on the guideline development process, please read how we develop NICE guidelines